Updates on Myopia : A Clinical Perspective.
Main Author: | |
---|---|
Other Authors: | |
Format: | eBook |
Language: | English |
Published: |
Singapore :
Springer Singapore Pte. Limited,
2019.
|
Edition: | 1st ed. |
Subjects: | |
Online Access: | Click to View |
Table of Contents:
- Intro
- Preface
- Acknowledgments
- Contents
- About the Editors
- 1: Introduction and Overview on Myopia: A Clinical Perspective
- 1.1 Global Epidemiology
- 1.2 Pathogenesis of Myopia
- 1.3 Key Environmental Factors on Myopia
- 1.4 Genetics of Myopia
- 1.5 Prevention of the Onset of Myopia
- 1.6 Understanding Pathologic Myopia
- 1.7 Imaging in Myopia
- 1.8 Glaucoma in Myopia
- 1.9 Management of Myopic Choroidal Neovascularization
- 1.10 Management of Myopia-Related Retinal Complications
- 1.10.1 Proposed Adjuncts to Improve Outcome of Macular Hole Surgery
- 1.11 Management and Control of Myopia in Children
- References
- 2: Global Epidemiology of Myopia
- 2.1 Introduction
- 2.2 Prevalence of Myopia in Children
- 2.2.1 Asian Countries
- 2.2.1.1 East Asian Countries and Singapore
- 2.2.1.2 Rest of Asian Countries
- 2.2.2 Non-Asian Countries
- 2.2.3 Urban and Rural Areas
- 2.3 Prevalence of Myopia and HM in Teenagers and Young Adults
- 2.3.1 East Asian Countries
- 2.3.2 Rest of East Asian Countries
- 2.4 Prevalence of Myopia and HM in Adults
- 2.4.1 Asian Countries
- 2.4.1.1 East Asian Countries
- 2.4.1.2 Rest of East Asian Countries
- 2.4.2 Non-Asian Countries
- 2.4.3 Generational Gap
- 2.5 The Prevalence of PM
- 2.6 Conclusion
- References
- 3: The Economic and Societal Impact of Myopia and High Myopia
- 3.1 Introduction
- 3.2 Economic Impact of Myopia
- 3.3 Secondary Impact of Myopia from Other Eye Diseases and Sight Loss
- 3.4 Quality of Life
- 3.5 Impact of Myopia Treatments on Quality of Life
- 3.6 Summary
- References
- 4: Understanding Myopia: Pathogenesis and Mechanisms
- 4.1 Emmetropization and Normal Ocular Growth in Human Eyes
- 4.2 Ocular Biometric Changes in Human Myopia
- 4.2.1 Cornea
- 4.2.2 Crystalline Lens and Anterior Chamber Depth.
- 4.2.3 Vitreous Chamber and Axial Length
- 4.2.4 Choroid
- 4.2.5 Sclera
- 4.3 Visual Environment, Emmetropization, and Myopia: Evidence from Animal Models
- 4.3.1 Form-Deprivation Myopia
- 4.3.2 Lens Defocus Ametropias
- 4.3.3 Comparing Form-Deprivation and Lens Defocus
- 4.4 Other Visual Cues for Emmetropization
- 4.4.1 Retinal Physiology
- 4.4.2 Aberrations
- 4.4.3 Accommodation
- 4.4.4 Circadian Rhythms
- 4.5 Effects of Key Environmental Factors on Myopia
- 4.5.1 Near Work and Education
- 4.5.2 Urbanization
- 4.5.3 Light Exposure
- 4.6 Conclusion
- References
- 5: The Genetics of Myopia
- 5.1 Introduction
- 5.2 Heritability
- 5.3 Syndromic Myopia
- 5.4 Linkage Studies
- 5.5 Candidate Gene Studies
- 5.6 Genome-Wide Association Studies
- 5.7 Pathway Analysis Approaches
- 5.8 Next Generation Sequencing
- 5.9 Environmental Influences Through Genetics
- 5.10 Epigenetics
- 5.11 Implications for Clinical Management
- 5.12 Concluding Remarks
- References
- 6: Risk Factors for Myopia: Putting Causal Pathways into a Social Context
- 6.1 Key Issues When Studying Risk Factors for Myopia
- 6.1.1 Myopia Is Etiologically Heterogeneous
- 6.1.2 Myopia Is a Developmental Condition
- 6.1.3 Cycloplegia and Definitions of Myopia: Important Methodological Issues
- 6.1.4 Myopia: The Importance of Causal Pathways
- 6.1.5 Statistical Analysis
- 6.2 The Main Risk Factors for "School Myopia": Education and Time Outdoors
- 6.2.1 The Search for Causal Mechanisms for Education
- 6.2.2 Protection by Time Outdoors
- 6.3 Other Possible Risk Factors for Myopia
- 6.3.1 Use of Computers and Smart Phones
- 6.3.2 Sex
- 6.3.3 Ethnicity
- 6.3.4 Parental Myopia
- 6.3.5 Intelligence
- 6.3.6 Urban/Rural Differences
- 6.3.7 Pollution
- 6.3.8 Housing
- 6.3.9 Height
- 6.3.10 Diet.
- 6.3.11 Sleep
- 6.3.12 Smoking
- 6.3.13 Birth Order
- 6.3.14 Season of Birth
- 6.3.15 Allergic Conjunctivitis: Hay Fever and Kawasaki Disease
- 6.3.16 Febrile Diseases
- 6.3.17 Fertility Treatment
- 6.4 Popular Beliefs About the Causes of Myopia
- 6.5 Comparing Genetic and Environmental Effects
- 6.6 Conclusions
- References
- 7: Prevention of Myopia Onset
- 7.1 Introduction
- 7.2 Onset of Myopia
- 7.3 Increased Time Outdoors as an Intervention
- 7.4 Reduced Near Work Intensity as an Intervention
- 7.5 Optical Interventions
- 7.6 Eye Exercises of Acupoints
- 7.7 Future Prospects
- References
- 8: Clinical Management and Control of Myopia in Children
- 8.1 Introduction
- 8.2 Near Activity and Accommodation
- 8.2.1 Bifocal and Progressive Addition Spectacles
- 8.2.2 Atropine
- 8.3 Peripheral Defocus
- 8.3.1 Peripheral Myopic Defocus Glasses
- 8.3.2 Bifocal or Dual-Focus Contact Lenses
- 8.3.3 Orthokeratology
- 8.4 Time Spent Outdoors
- 8.4.1 Environmental Interventions
- 8.4.2 Higher Light Intensities and Dopamine
- 8.5 Inheritance and Genetics of Myopia
- 8.6 Application to Clinical Practice
- 8.7 Conclusion
- References
- 9: Understanding Pathologic Myopia
- 9.1 Introduction
- 9.2 Definition of Pathologic Myopia
- 9.3 Posterior Staphyloma
- 9.3.1 Definition of Staphyloma by Spaide (Fig. 9.1)
- 9.3.2 Detection of Posterior Staphyloma
- 9.3.3 Classification (Ohno-Matsui's Modified Classification, Fig. 9.3)
- 9.4 Fundus Complications of Pathologic Myopia
- 9.4.1 Myopic Chorioretinal Atrophy (META-PM Study, Table 9.1)
- 9.4.2 Diffuse Chorioretinal Atrophy (Category 2)
- 9.4.3 Patchy Chorioretinal Atrophy (Category 3)
- 9.4.4 Lacquer Cracks (Plus Sign)
- 9.4.5 Myopic CNV and CNV-Related Macular Atrophy
- 9.5 Myopic Macular Retinoschisis.
- 9.6 Dome-Shaped Macula (DSM)
- References
- 10: Imaging in Myopia
- 10.1 Introduction
- 10.2 Disease Characteristics of Myopia
- 10.3 Key Structures Altered in Myopia and Pathological Myopia
- 10.3.1 Sclera and Collagen
- 10.3.2 Choroidal Changes
- 10.3.3 Bruch's Membrane and Retinal Pigment Epithelium Changes
- 10.4 Existing Imaging Modalities to Evaluate the Myopic Eye
- 10.4.1 Optical Coherence Tomography
- 10.4.2 Ultrasound
- 10.4.3 Magnetic Resonance Imaging
- 10.5 Challenges in Imaging of the Myopic Eye
- 10.5.1 Interaction Between Low- and High-Order Aberrations
- 10.5.2 Challenges in Imaging the Anterior Segment
- 10.5.3 Challenges in Imaging the Retina
- 10.5.4 Challenges in Imaging the Choroid and Sclera
- 10.5.5 Challenges in Imaging the Optic Nerve
- 10.6 Future Developments
- References
- 11: Glaucoma in High Myopia
- 11.1 Introduction
- 11.2 Anatomy of the Optic Nerve Head in High Myopia
- 11.3 Increased Prevalence of Glaucoma in High Myopia and Associated Factors
- 11.4 Potential Reasons for the Association Between Glaucoma and High Myopia
- 11.5 Intraocular Pressure and Glaucoma in High Myopia
- 11.6 Therapy of Glaucoma in High Myopia
- References
- 12: Clinical Management of Myopia in Adults: Treatment of Retinal Complications
- 12.1 Introduction
- 12.2 Surgical Procedures
- 12.2.1 Pars Plana Vitrectomy
- 12.2.1.1 Microincision Vitrectomy Surgery
- 12.2.1.2 Induction of Posterior Vitreous Detachment
- 12.2.1.3 Epiretinal Membrane Peeling
- 12.2.1.4 Internal Limiting Membrane Peeling
- Full-Thickness Macular Hole
- Myopic Foveoschisis
- 12.2.1.5 Gas Tamponade
- 12.2.2 Additional Measures (Adjuncts) to Improve Outcome of Macular Hole Surgery
- 12.2.2.1 Endotamponade
- 12.2.2.2 Inverted Internal Limiting Membrane Flap.
- 12.2.2.3 Autologous Internal Limiting Membrane Transplantation
- 12.2.2.4 Autologous Blood
- 12.2.2.5 Lens Capsular Flap Transplantation
- 12.2.2.6 Macular Buckle
- 12.2.2.7 Autologous Neurosensory Retinal Transplantation
- 12.3 Conclusion
- References
- 13: Clinical Management of Myopia in Adults: Treatment of Myopic CNV
- 13.1 Disease Overview
- 13.2 Incidence and Prevalence
- 13.3 Natural History
- 13.4 Risk Factors
- 13.5 Pathogenesis
- 13.6 Diagnosis and Monitoring
- 13.7 Differential Diagnosis
- 13.7.1 Macular Hemorrhage Secondary to Lacquer Cracks (Fig. 13.2)
- 13.7.2 Inflammatory CNV
- 13.7.3 Dome-Shaped Maculopathy with Serous Detachment
- 13.8 Management
- 13.8.1 Anti-Vascular Endothelial Growth Factor Drugs
- 13.9 Ranibizumab
- 13.10 Aflibercept
- 13.11 Bevacizumab
- 13.12 Conbercept
- 13.13 Factors Related to Treatment Outcomes
- 13.14 Recurrence
- 13.15 Treatment Regimen and Follow-Up
- 13.16 Long-Term Outcomes
- 13.17 Conclusions
- References
- 14: Optical Interventions for Myopia Control
- 14.1 Introduction
- 14.2 Spectacle Lenses
- 14.2.1 Under-Correction of Myopia
- 14.2.2 Bifocal or Multifocal Spectacles
- 14.3 Contact Lenses
- 14.3.1 Rigid Gas Permeable Contact Lenses
- 14.3.2 Orthokeratology
- 14.3.3 Soft Bifocal and Multifocal Contact Lenses
- 14.4 Others: Outdoor Activities and Violet Light Transmitting Lenses
- 14.5 Comparison of the Effectiveness on Myopia Control by Different Optical Interventions
- 14.6 Conclusions
- References
- Correction to: Optical Interventions for Myopia Control
- Correction to: M. Ang, T. Y. Wong (eds.), Updates on Myopia, https://doi.org/10.1007/978-981-13-8491-2_14.